Your dog was diagnosed with Thyroid Carcinoma. ~1-4% of all canine tumours. ~90% of thyroid tumours in dogs are malignant (unlike cats where ~90% are benign). Most are non-functional (euthyroid). Mobile tumours have much better surgical prognosis than fixed/invasive. Compare 4 treatment options for dogs including Thyroidectomy (Mobile Tumours), High-Dose Radioactive Iodine (I-131), External Beam Radiation Therapy (Fixed Tumours) — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Thyroid Carcinoma
Canine Oncology Treatment Guide
Thyroid Carcinoma
Mobile vs Fixed/Invasive
Epithelial
About This Cancer
Thyroid carcinoma is a cancer of the thyroid gland, an endocrine organ consisting of two lobes situated on either side of the windpipe in the neck, which regulates metabolism. In dogs, unlike in cats, the vast majority (approximately 90%) of thyroid tumours are malignant. However, most canine thyroid carcinomas are non-functional, meaning they do not produce excess thyroid hormones and the dog remains euthyroid (normal hormone levels). A key prognostic distinction is whether the tumour is freely mobile under the skin or fixed to surrounding tissues: mobile tumours are typically well-encapsulated and can be completely removed surgically with an excellent prognosis, while fixed, invasive tumours have already grown into surrounding structures and are much more challenging to treat. Beagles, Golden Retrievers, and Siberian Huskies appear to be at somewhat increased risk.
Clinical staging for canine thyroid carcinoma
Primarily classified by mobility (mobile vs fixed) which dictates treatment approach
Prognostic Factors(4)
Minimum Workup(8 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.